These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 17709319

  • 1. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME, Fleming MD, Pinkus JL, Pinkus GS.
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [Abstract] [Full Text] [Related]

  • 2. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M, Conrad C, Kamarashev J, Asagoe K, Cozzio A, Burg G, Dummer R.
    Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M, Jones D.
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
    Ng AP, Lade S, Rutherford T, McCormack C, Prince HM, Westerman DA.
    Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S, Malugani F, Rovati B, Porta C, Riccardi A, Danova M.
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
    Shiman M, Marchione R, Ricotti C, Romanelli P, Alonso-Llamazares J.
    Dermatol Online J; 2008 Nov 15; 14(11):5. PubMed ID: 19094843
    [Abstract] [Full Text] [Related]

  • 18. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.
    Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, Béné MC, Bensa JC, Brière F, Plumas J.
    Haematologica; 2003 Aug 15; 88(8):941-55. PubMed ID: 12935983
    [Abstract] [Full Text] [Related]

  • 19. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
    Hallermann C, Middel P, Griesinger F, Gunawan B, Bertsch HP, Neumann C.
    Eur J Dermatol; 2004 Aug 15; 14(5):317-22. PubMed ID: 15358570
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.